RPX’s CEO released a statement on our response to the COVID-19 emergency. Click here to access.

RPX’s CEO released a statement on our response to the COVID-19 emergency. Click here to access.

Blood glucose tracking apparatus and methods

  • US 8,236,242 B2
  • Filed: 02/12/2010
  • Issued: 08/07/2012
  • Est. Priority Date: 04/02/2001
  • Status: Active Grant
  • ×

    Create Patent Alert


    *Certain alert events are not available for your current subscription level. Upgrade
  • Save